Skip to main content
Fig. 1 | BMC Rheumatology

Fig. 1

From: Using the derived 28-joint disease activity score patient-reported components (DAS28-P) index as a discriminatory measure of response to disease-modifying anti-rheumatic drug therapy in early rheumatoid arthritis

Fig. 1

DAS28 and DAS28 component scores (predicted marginal means) during the first year of treatment for the three responder groups. A DAS28-ESR B DAS28—Objective Component C DAS28—Subjective Component D DAS28-P (an index defined by DAS28—Subjective Component/DAS28-ESR)

Back to article page

BMC Rheumatology

ISSN: 2520-1026

Contact us